3Simchen C,Lehmann 1,Sittig D,et al. Expression and regulation of regulated on activation normal T cells expressed and secreted in thyroid tissue of patients with Graves'disease and thyroid autonomy and in thyroid-derived cell populations. J Clin Endocrinol Metab ,2000,85 ( 12 ) :4 758.
4Bartalena L, Marcocci C, Pinchera A. Cytokine antagonists:new ideas for the management of Graves' ophthalmopathy. J Clin Endocrinol Metab, 1996,81 ( 2 ) :446.
5Aust G, Steinert M, Lamesch P, et al. Graves disease is associated with an alter CXCR3 and CCR5 expression in thyroid-derived compared to peripheral blood lymphocytes. Clin Exp Immunol,2002,127(3 ) :479.
6Hiromatsu Y,Yang D, Bednarczuk T, et al. Cytokine profiles in eye muscle tissue and orbital fat tissue from patients with thyroid-associated ophthalmopathy. J Clin Endocrinol Metab,2000,85(3) :1 194.
7Ruiz-Ortega M, Bustos C, Hernandez-Presa MA, et al. Angiotensin Ⅱ participates in mononuclear cell recruitment in experimental immune complsx nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis. J Immunol, 1998,161 (1) :430.
8Das KC, Lewis-Molock Y, White CW. Thiol modulation of TNF alpha and IL-1 induced MnSOD gene expression and activation of NF-kappa B. Mol Cell Biochem, 1995, 148(1) :45.
9Zoja C, Donadelli R, Colleoni S, et al. Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation. Kidney Int, 1998,53(6) :1 608.
10Gruber PJ, Torres-Rosado A, Wolak ML,et al. Apo CⅢ gene transcription is regulated by a cytokine inducible NF-kappa B element. Nucleic Acids Res,1994,22(12) :2 417.